NEW YORK (GenomeWeb News) – Myriad Genetics said after the close of the market Tuesday that it expects its fourth-quarter and full-year 2009 molecular diagnostic revenues to be lower than previously expected.

The Salt Lake City-based firm said that it expects to report fourth-quarter molecular diagnostic revenues of $86 million. Analysts, on average, were expecting revenues of $91.6 million for the quarter ended June 30.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.